Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
Authors
Keywords
Predictive Preventive Personalized Medicine, Market access, Value, Strategy, Companion diagnostics, Cost-effectiveness, Reimbursement, Health technology assessment, Economic models
Journal
EPMA Journal
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-30
DOI
10.1186/s13167-015-0041-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
- (2015) F Fitzal et al. BRITISH JOURNAL OF CANCER
- EPMA position paper in cancer: current overview and future perspectives
- (2015) Godfrey Grech et al. EPMA Journal
- Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence
- (2014) Norman L. Foster et al. Alzheimers & Dementia
- KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
- (2014) Marie Westwood et al. HEALTH TECHNOLOGY ASSESSMENT
- Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non–Small-Cell Lung Cancer
- (2014) Adam Falconi et al. Journal of Thoracic Oncology
- Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer
- (2013) Eldon Spackman et al. PHARMACOECONOMICS
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
- (2013) Elisabeth Drucker et al. EPMA Journal
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
- (2012) Olga Golubnitschaja et al. EPMA Journal
- Willingness to Pay for Genetic Testing for Alzheimer's Disease: A Measure of Personal Utility
- (2011) Ilona M. Kopits et al. Genetic Testing and Molecular Biomarkers
- Molecular Markers in the Treatment of Metastatic Colorectal Cancer
- (2010) Peter M. Wilson et al. CANCER JOURNAL
- Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2009) Judith A. Aberg et al. CLINICAL INFECTIOUS DISEASES
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Additional Patient Outcomes and Pathways in Evaluations of Testing
- (2009) Patrick M. M. Bossuyt et al. MEDICAL DECISION MAKING
- Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations
- (2009) Thomas A. Trikalinos et al. MEDICAL DECISION MAKING
- Understanding the Medical and Nonmedical Value of Diagnostic Testing
- (2009) David W. Lee et al. VALUE IN HEALTH
- Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
- (2008) Juhi Asad et al. AMERICAN JOURNAL OF SURGERY
- Peptide Nucleic Acid Fluorescent In Situ Hybridization for Hospital-Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy
- (2008) G. N. Forrest et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
- (2008) Scott D Grosse et al. GENETICS IN MEDICINE
- Assessing The Comparative Effectiveness Of A Diagnostic Technology: CT Colonography
- (2008) Steven D. Pearson et al. HEALTH AFFAIRS
- An evaluation of the performance of OraQuick® ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK
- (2008) J Zelin et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now